X4P-001 and Pembrolizumab in Patients With Advanced Melanoma
NCT02823405
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Melanoma
Interventions
DRUG:
X4P-001
DRUG:
Pembrolizumab
Sponsor
X4 Pharmaceuticals